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Background
Low status of 25-hydroxyvitamin D [25(OH)D] is
defined as level< 30ng/mL. Studies indicate high preva-
lence of hypovitaminosis D at different ages in many
regions of Brazil. It is associated with decreased insulin
sensitivity and reduced pancreatic b-cell function. Berar-
dinelli-Seip Syndrome (BS) is a rare congenital autoso-
mal recessive disease due to mutations in 4 main genes
(AGPAT2, BSCL2, CAV1 and PTRF). It presents lack of
metabolically active fat, and ectopic adipose storage in
liver and skeletal muscle, impaired metabolism of lipids
and carbohydrates, insulin resistance, diabetes mellitus
(DM) and dyslipidemia. We did not find in the literature
descriptions about levels of 25(OH)D in groups of
patients with BS.
Objective
To describe 25(OH)D blood levels and its correlation
with insulin, glycosylated hemoglobin (A1c), HOMA-IR
and hepatic steatosis in patients.
Materials and methods
Cross-sectional study conducted between 2013 and
2014. We evaluated 13 patients with BS followed at a
University Hospital. Blood dosage of 25(OH)D, insulin,
A1c, HOMA-IR, abdominal ultrasound and genetic
study was made. Associations were tested by Spearman's
rank correlaction coefficient.
Results
The results were expressed as median, 25th percentile
and 75th percentile for 25(OH)D levels, mean and stan-
dard deviation for other laboratory tests, and absolute
frequency for the other variables. The median of 25
(OH)D was 36.3 (26.3 – 40.5) ng/mL. Nine patients pre-
sented normal levels of 25(OH)D, with median of 40.5
(36.3-42.1) ng/mL, 2 presented insufficiency (26 ng/mL)
and 2 presented deficiency (18.2 ng/mL). Among other
variables, 6 patients had DM, 12 hepatomegaly and 4
hepatic steatosis. All patients had severe low leptin
levels (1.2±0.3 ng/mL). Four patients showed mutation
on AGPAT2 gene, and 6 on BSCL2. The genetic study
of 3 patients is in progress. The correlation coefficients
between 25(OH)D levels and insulin, A1c, HOMA-IR,
DM, and hepatic steatosis were not significant.
Conclusion
In this study there was an unexpected predominance of
normal levels of 25(OH)D in patients with BS, which is
not an usual finding in Brazilian population nowadays.
Some authors hypothesize that high leptin levels impairs
the synthesis of 25(OH)D in obese. It may suggest a
possible role of leptin deficiency in the 25(OH)D suffi-
ciency in BS. Another hypothesis are that excess of sub-
cutaneous fat would sequester vitamin D and that
hepatic injury would result in low 25(OH)D synthesis.
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